Diabetes-Teleconference - What's Up?

Discussion in 'AstraZeneca' started by anonymous, Oct 8, 2015 at 2:08 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Oh boy! Here we go- it's just the start of B - shit !
     

  2. anonymous

    anonymous Guest

    I'll tell you what's up. Onglyza is circling the drain and taking with it any hopes of a saxa/dapa launch. Layoffs in diabetes are coming soon.
     
  3. anonymous

    anonymous Guest

    Right on brother - most likely all smoke and mirrors tomorrow . Look for key words or phases that tell the real story to come!
     
  4. anonymous

    anonymous Guest

    Here come the rumors. More than likely they are moving the launch to first part of 2016. I hope they give this pos to contract but apparently az has no clue as usual. Look at merck. Why is januvia growing. Simple. One rep selling only their dpp4. They have coverage. And by the way they are using our study that we blew off against us. But once again. Az doesnt want to hear the truth. The same reason bydureon is failing, it doesnt take a fricking mba to know that victoza reps already have the prior auth forms completed for the dumb ass bump and dont forget patients still like free but az is to fricking stupid to want to see or hear the truth
     
  5. anonymous

    anonymous Guest

    Really , they are not having it next month that's for certain. I think it's done , to many negatives and why drag down Farxiga by attaching it to Onglyza.
     
  6. anonymous

    anonymous Guest

    When Prilosec (not Nexium) grew big time, it was not because of salesmanship on the part of the reps. You are a PR employee, that's it. If the mousetrap sucks forget about it. If it's better, the sales are increasing not because of you.

    We are in a new world. There is information available now.
     
  7. anonymous

    anonymous Guest

    That's what happens when you removed multiple salesmen from the specialists. They suffer and it trickles down to other customers.
     
  8. anonymous

    anonymous Guest

    Farxiga will never never challenge the leader Invokana. Less effective, worse managed care and remember bladder cancer is in insert not with Invokana
     
  9. anonymous

    anonymous Guest

    i guess you sell Invonkana , but not in my area , because you would be crying to mommy how my team has been wiping you off the map . No go take those free Meds you get from JJ and call mom! A-wipe
     
  10. anonymous

    anonymous Guest

    Boy are all of you paranoid as hell! All is fine! Frenchie has it under control. Nothing to worry about. They should have canned 50% already, and if they were, it would have already been announced! Continue with the call faking, stealing and backstabbing! In other words, it's business as usual at AZ!
     
  11. anonymous

    anonymous Guest

    Well that didn't sound very convincing, Topher. What's really going on?
     
  12. anonymous

    anonymous Guest

    Hospital here. What did Topher have to say?
     
  13. anonymous

    anonymous Guest

    You are a legend. No one will deny that. The reality is Invokana is killing it nationally. Always will. I looked at the financials from both companies in the SGLT2 class. Invokana is simply destroying Farxiga nationally
     
  14. anonymous

    anonymous Guest

    We are in the drivers seat. Will launch this product when we want too.
    Hospital will be expanded due to your impact on IDN's.
    We need more Endo voice to continue our dominance in diabetes.
    We will keep are sales forces separated for greater sales potential.
    There will be no collaboration between sales forces. This hurts are market shares.
     
  15. anonymous

    anonymous Guest

    you the man , I do not give a shit about national numbers it's all about me and my area. That's what puts food on my table , Invonkana reps get my crumbs lol
     
  16. anonymous

    anonymous Guest

    Never has anything been more true. Well said.
     
  17. anonymous

    anonymous Guest

    Jardiance has been getting all of the positive press lately. When BI and Lilly get their heads out of their asses and start flooding the streets with reps pushing studies that we won't have ready until 2017, we're fucked.
     
  18. anonymous

    anonymous Guest

    Two words , just whipper the them ( class effect)
     
  19. anonymous

    anonymous Guest

    when you hear the words "it's great for the class" from our leaders, I think you know what they are referring too. We don't lead we follow. Marketing, management, sales models,etc.

    We look at trends and react to the market. Great companies set the trend and force other companies to follow.
     
  20. anonymous

    anonymous Guest

    Just remember that someone in sales received an award for the idea of filling candy jars in Doctor's offices with purple jelly beans. That was pure genius.